107 related articles for article (PubMed ID: 1711873)
1. The role of different types of corticosteroids on the inflammatory mediators in cardiopulmonary bypass.
Jansen NJ; van Oeveren W; van Vliet M; Stoutenbeek CP; Eysman L; Wildevuur CR
Eur J Cardiothorac Surg; 1991; 5(4):211-7. PubMed ID: 1711873
[TBL] [Abstract][Full Text] [Related]
2. Inhibition by dexamethasone of the reperfusion phenomena in cardiopulmonary bypass.
Jansen NJ; van Oeveren W; van den Broek L; Oudemans-van Straaten HM; Stoutenbeek CP; Joen MC; Roozendaal KJ; Eysman L; Wildevuur CR
J Thorac Cardiovasc Surg; 1991 Oct; 102(4):515-25. PubMed ID: 1656149
[TBL] [Abstract][Full Text] [Related]
3. The effect of methylprednisolone treatment on the cardiopulmonary bypass-induced systemic inflammatory response.
Bourbon A; Vionnet M; Leprince P; Vaissier E; Copeland J; McDonagh P; Debré P; Gandjbakhch I
Eur J Cardiothorac Surg; 2004 Nov; 26(5):932-8. PubMed ID: 15519185
[TBL] [Abstract][Full Text] [Related]
4. Reduced complement activation during cardiopulmonary bypass does not affect the postoperative acute phase response.
van den Goor J; Nieuwland R; van den Brink A; van Oeveren W; Rutten P; Tijssen J; Eijsman L
Eur J Cardiothorac Surg; 2004 Nov; 26(5):926-31. PubMed ID: 15519184
[TBL] [Abstract][Full Text] [Related]
5. Cardiopulmonary bypass circuit treated with surface-modifying additives: a clinical evaluation of blood compatibility.
Gu YJ; Boonstra PW; Rijnsburger AA; Haan J; van Oeveren W
Ann Thorac Surg; 1998 May; 65(5):1342-7. PubMed ID: 9594864
[TBL] [Abstract][Full Text] [Related]
6. The effects of methylprednisolone on complement, immunoglobulins and pulmonary neutrophil sequestration during cardiopulmonary bypass.
Dernek S; Tünerir B; Sevin B; Aslan R; Uyguç O; Kural T
Cardiovasc Surg; 1999 Jun; 7(4):414-8. PubMed ID: 10430523
[TBL] [Abstract][Full Text] [Related]
7. Leukocyte activation with increased expression of CR3 receptors during cardiopulmonary bypass.
Gu YJ; van Oeveren W; Boonstra PW; de Haan J; Wildevuur CR
Ann Thorac Surg; 1992 May; 53(5):839-43. PubMed ID: 1315132
[TBL] [Abstract][Full Text] [Related]
8. Effects of methylprednisolone and a biocompatible copolymer circuit on blood activation during cardiopulmonary bypass.
Rubens FD; Nathan H; Labow R; Williams KS; Wozny D; Karsh J; Ruel M; Mesana T
Ann Thorac Surg; 2005 Feb; 79(2):655-65. PubMed ID: 15680854
[TBL] [Abstract][Full Text] [Related]
9. Effect of methylprednisolone on complement activation during heparin neutralization.
Loubser PG
J Cardiovasc Pharmacol; 1997 Jan; 29(1):23-7. PubMed ID: 9007666
[TBL] [Abstract][Full Text] [Related]
10. Effects of aprotinin on hemostatic mechanisms during cardiopulmonary bypass.
van Oeveren W; Jansen NJ; Bidstrup BP; Royston D; Westaby S; Neuhof H; Wildevuur CR
Ann Thorac Surg; 1987 Dec; 44(6):640-5. PubMed ID: 2446574
[TBL] [Abstract][Full Text] [Related]
11. [Use of cardiopulmonary bypass decreases leukocyte count and activation of the complement system].
Bochenek A; Religa Z; Kokot F; Knapik P; Wnuk R; Komarski K; Wojnar J; Pietrzycki A; Skiba J
Kardiol Pol; 1992; 36(2):67-72. PubMed ID: 1583828
[TBL] [Abstract][Full Text] [Related]
12. Effect of sodium nitroprusside on complement activation induced by cardiopulmonary bypass: a clinical and experimental study.
Seghaye MC; Duchateau J; Grabitz RG; Wolff T; Marcus C; Engelhardt W; Hörnchen H; Messmer BJ; von Bernuth G
J Thorac Cardiovasc Surg; 1996 Apr; 111(4):882-92. PubMed ID: 8614150
[TBL] [Abstract][Full Text] [Related]
13. Methylprednisolone inhibits increase of interleukin 8 and 6 during open heart surgery.
Kawamura T; Inada K; Okada H; Okada K; Wakusawa R
Can J Anaesth; 1995 May; 42(5 Pt 1):399-403. PubMed ID: 7614647
[TBL] [Abstract][Full Text] [Related]
14. The effects of methylprednisolone on complement-mediated neutrophil activation during cardiopulmonary bypass.
Tennenberg SD; Bailey WW; Cotta LA; Brodt JK; Solomkin JS
Surgery; 1986 Aug; 100(2):134-42. PubMed ID: 3738745
[TBL] [Abstract][Full Text] [Related]
15. Reducing the effects of the systemic inflammatory response to cardiopulmonary bypass: can single dose steroids blunt systemic inflammatory response syndrome?
Sobieski MA; Graham JD; Pappas PS; Tatooles AJ; Slaughter MS
ASAIO J; 2008; 54(2):203-6. PubMed ID: 18356656
[TBL] [Abstract][Full Text] [Related]
16. Systemic inflammatory response related to cardiopulmonary bypass and its modification by methyl prednisolone: high dose versus low dose.
Varan B; Tokel K; Mercan S; Dönmez A; Aslamaci S
Pediatr Cardiol; 2002; 23(4):437-41. PubMed ID: 12170362
[TBL] [Abstract][Full Text] [Related]
17. Effects of urinary protease inhibitor on inflammatory response during on-pump coronary revascularisation. Effect of ulinastatin on inflammatory response.
Bingyang J; Jinping L; Mingzheng L; Guyan W; Zhengyi F
J Cardiovasc Surg (Torino); 2007 Aug; 48(4):497-503. PubMed ID: 17653011
[TBL] [Abstract][Full Text] [Related]
18. [Effects of ulinastatin on plasma polymorphonuclear leukocyte elastase activity and respiratory function in patients undergoing cardiopulmonary bypass].
Mishima A; Takeuti Y; Usami S; Kotani H; Suzuki Y; Yura J
Nihon Kyobu Geka Gakkai Zasshi; 1990 Apr; 38(4):607-12. PubMed ID: 2373894
[TBL] [Abstract][Full Text] [Related]
19. The acute cardioprotective effect of glucocorticoid in myocardial ischemia-reperfusion injury occurring during cardiopulmonary bypass.
Enc Y; Karaca P; Ayoglu U; Camur G; Kurc E; Cicek S
Heart Vessels; 2006 May; 21(3):152-6. PubMed ID: 16715189
[TBL] [Abstract][Full Text] [Related]
20. Effect of the neutrophil elastase inhibitor sivelestat on perioperative inflammatory response after pediatric heart surgery with cardiopulmonary bypass: a prospective randomized study.
Kohira S; Oka N; Inoue N; Itatani K; Hanayama N; Kitamura T; Fujii M; Takeda A; Oshima H; Tojo K; Yoshitake S; Miyaji K
Artif Organs; 2013 Dec; 37(12):1027-33. PubMed ID: 23834653
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
